Oral fexinidazole for human African trypanosomiasis
Oral fexinidazole for human African trypanosomiasis
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
In this context, the findings of the study by Victor Kande Betu Ku Mesu and colleagues7 in The Lancet are of great importance. In their randomised, phase 2/3 non-inferiority trial, the researchers compared the efficacy and safety of fexinidazole, an oral nitroimidazole analogue given once a day (1800 mg on days 1-4 and 1200 mg on days 5-10), with n...
Alternative Titles
Full title
Oral fexinidazole for human African trypanosomiasis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1989911495
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1989911495
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(18)30019-9
